T lymphocytes restrain spontaneous metastases in permanent dormancy

Area of Science:

• Immunology
• Oncology
• Cancer Research

Background:

• Tumor dormancy is crucial in cancer immunoediting, but its mechanisms in metastases are unclear.
• Preclinical models for studying dormant metastases are lacking.
• Immune equilibrium plays a role in maintaining tumor dormancy.

Purpose of the Study:

• To establish a preclinical model for studying spontaneous, immune-mediated tumor dormancy.
• To investigate the immune mechanisms responsible for maintaining metastatic dormancy.
• To explore the potential of immunotherapy for managing metastatic disease.

Main Methods:

• Injection of GR9-B11 mouse fibrosarcoma clone into syngeneic BALB/c mice.
• Observation of spontaneous metastases over 24 months.
• Immunodepletion of T lymphocytes and asialo GM1-positive cells in tumor-bearing mice.
• Analysis of MHC class I expression on tumor cells.

Main Results:

• A nontransgenic mouse model demonstrated permanent, immune-mediated dormancy of spontaneous metastases.
• Immunodepletion of T lymphocytes or asialo GM1-positive cells led to the progression of lung metastases.
• The immune system was shown to restrain spontaneous metastases, maintaining permanent dormancy.
• GR9-B11 tumor cells lacked MHC class I, but metastases in immunodepleted mice were MHC class I-positive.

Conclusions:

• The developed mouse model effectively replicates immune-mediated tumor dormancy.
• Immune surveillance, particularly involving T lymphocytes and asialo GM1-positive cells, is critical for maintaining metastatic dormancy.
• This model offers a platform for studying metastatic dormancy and developing immunotherapies for metastatic cancer.